Integrative Cancer Therapies

Integrative Cancer Therapies is an open access peer-reviewed journal published by SAGE Publications, founded in 2002, focused on integrative oncology, namely the scientific validation of complementary and traditional therapies and their responsible integration with conventional cancer treatment, with a 2025 impact factor of 3.1（Integrative Cancer Therapies）是 SAGE Publications 出版的开放获取同行评审期刊，2002 年创刊，聚焦整合肿瘤学，即以科学方法验证替代与传统医学疗法并负责任地将其与常规肿瘤治疗结合，2025 年影响因子为 3.1。

Scope

• It focuses on a new and growing movement in cancer treatment聚焦肿瘤治疗中一场新兴且不断壮大的运动。
• Integrative cancer treatment includes therapeutic interventions in the areas of diet, lifestyle, exercise, stress care and nutritional supplements整合肿瘤治疗涵盖饮食、生活方式、运动、压力管理与营养补充剂等领域的治疗干预。
• It emphasises scientific validation of these therapies and of therapies from culturally diverse medical traditions such as herbs, massage, yoga and other meditative movement therapies强调对上述疗法及来自多元文化医学传统（如草药、按摩、瑜伽及其它冥想运动疗法）的疗法进行科学验证。
• The responsible integration of integrative therapies with conventional oncology treatment is a major focus, and the use of alternative medical therapies is also explored整合疗法与常规肿瘤治疗负责任地结合是主要焦点，同时探讨替代医学疗法的使用。
• It also covers innovative therapies in rapidly advancing areas of medicine such as circadian biology, the microbiome and immune-based therapies还涵盖昼夜节律生物学、微生物组与免疫疗法等快速发展的医学领域的创新疗法。
• Article types include research articles, brief reports, review papers, case reports, educational articles, letters to the editor and invited commentaries文章类型包括研究论文、简报、综述、病例报告、教育文章、读者来信与约稿评论。

History

• It was founded in March 2002, with volume 1, number 1, and has been indexed by MEDLINE since volume 1, number 1该刊 2002 年三月创刊，第一卷第一期，自第一卷第一期起被 MEDLINE 收录。
• It was founded by SAGE as the first journal dedicated to integrative oncology, and its founding editor-in-chief is Keith I. Block, whose founding editorial appeared in the first issue由 SAGE 创办，是首本专注整合肿瘤学的期刊，创刊主编为 Keith I. Block，其创刊社论刊于创刊号。^[1]
• It has no former titles and has been published by SAGE Publications throughout该刊无曾用名，自创刊起一直由 SAGE Publications 出版。
• Its NLM publication place is Thousand Oaks, California, in the United StatesNLM 记出版地为美国加州千橡市。
• It has been quarterly since launch, converted from subscription to full open access in 2016, ceased print with volume 15 in 2016 and has been online-only since 2017, with articles published continuously and compiled into quarterly issues创刊即季刊，2016 年由订阅制转为完全开放获取，随 2016 年第 15 卷停印纸质版，2017 年起纯在线出版，文章连续发布并按季汇编成期。^[2]
• Its impact factor is 3.1, its five-year impact factor is 3.4, and its Scopus CiteScore is 5.3其影响因子为 3.1，五年影响因子为 3.4，Scopus CiteScore 为 5.3。

Editors

• Its editor-in-chief is Keith I. Block, MD, of the University of Illinois at Chicago and the Institute for Integrative Cancer Care in the United States现任主编 Keith I. Block，医学博士，美国伊利诺伊大学芝加哥分校与整合肿瘤治疗研究所。
• His field is integrative oncology, the combination of complementary and traditional therapies with conventional cancer treatment, and nutrition and lifestyle intervention其研究领域为整合肿瘤学、替代与传统疗法同常规肿瘤治疗的结合以及营养与生活方式干预。
• The associate editors are Penny Block, Bethany Elkington, Gail Mahady, Stephen Samuel and Peying Yang, all based in the United States副编辑为 Penny Block、Bethany Elkington、Gail Mahady、Stephen Samuel 与 Peying Yang，均在美国。
• Other posts include managing editor Charlotte Gyllenhaal, scientific editor Dale Shumaker, international editor Jacob Shoham of Bar-Ilan University in Israel, and statistics editor Jim Grutsch其它岗位包括执行编辑 Charlotte Gyllenhaal、学术编辑 Dale Shumaker、国际编辑以色列巴伊兰大学的 Jacob Shoham 与统计编辑 Jim Grutsch。
• The editorial board has about 60 members and is highly international, covering Canada, Australia, the United Kingdom, France, Germany, Italy, Spain, Sweden, Israel, Iran, India, Japan, Korea, Saudi Arabia, Singapore and China as well as Taiwan and Hong Kong编委会约 60 人，国际化程度高，涵盖加拿大、澳大利亚、英国、法国、德国、意大利、西班牙、瑞典、以色列、伊朗、印度、日本、韩国、沙特阿拉伯、新加坡与中国及台湾、香港。
• All articles are peer reviewed with single anonymised review, preprints are accepted, the journal follows the ICMJE, COPE and EQUATOR reporting standards and trials must be registered in a WHO-recognised registry, and it is fully open access with an article processing charge of 3000 US dollars and is online only with invited special collections所有文章经单盲同行评审，接受预印本，遵循 ICMJE、COPE 与 EQUATOR 报告规范，临床试验须在 WHO 认可注册库注册，且该刊为完全开放获取，文章处理费为 3000 美元，仅在线出版并设约稿专题集。